Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Capital Leases: 2015-2019

Historic Capital Leases for Enanta Pharmaceuticals (ENTA) over the last 5 years, with Sep 2019 value amounting to $200,000.

  • Enanta Pharmaceuticals' Capital Leases fell 31.74% to $200,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $200,000, marking a year-over-year decrease of 31.74%. This contributed to the annual value of $200,000 for FY2019, which is 31.74% down from last year.
  • Enanta Pharmaceuticals' Capital Leases amounted to $200,000 in FY2019, which was down 31.74% from $293,000 recorded in FY2018.
  • Over the past 5 years, Enanta Pharmaceuticals' Capital Leases peaked at $529,000 during FY2015, and registered a low of $200,000 during FY2019.
  • In the last 3 years, Enanta Pharmaceuticals' Capital Leases had a median value of $293,000 in 2018 and averaged $290,667.
  • Data for Enanta Pharmaceuticals' Capital Leases shows a maximum YoY slumped of 31.74% (in 2019) over the last 5 years.
  • Enanta Pharmaceuticals' Capital Leases (Yearly) stood at $529,000 in 2015, then dropped by 13.42% to $458,000 in 2016, then decreased by 17.25% to $379,000 in 2017, then decreased by 22.69% to $293,000 in 2018, then slumped by 31.74% to $200,000 in 2019.